Table 1.
Prognoses of pancreatic neuroendocrine tumor Grade 1 patients
| Sex | Age (yr) | Initial size (mm) | Location of tumor | Method of final diagnosis | Ki-67 index (%) | Mitotic count (/10 HPFs) | Function | Elevated tumor markers | Observation period (mo) | Tumor growth (mm) | |
| 1 | F | 79 | 19 | Body | Surgery | < 2.0 | 0 | No | No | 6 | No |
| 2 | F | 41 | 34 | Tail | Surgery | 0.9 | 2 | Yes | No | 80 | 76 |
| 3 | M | 69 | 3 | Body | Surgery | < 2.0 | 0 | Yes | No | 15 | No |
| 4 | M | 55 | 40 | Head | Surgery | < 1.0 | 0 | Yes | No | 6 | No |
| 5 | F | 73 | 32 | Head | Surgery | 1.3 | 0 | No | No | 9 | No |
| 6 | F | 81 | 4 | Head | EUS-FNA | < 1.0 | Difficult | No | No | 22 | No |
| 7 | F | 64 | 8 | Tail | EUS-FNA | 0.4 | Difficult | No | No | 17 | No |
| 8 | F | 70 | 8 | Body | EUS-FNA | < 1.0 | Difficult | No | No | 54 | No |
M: Male; F: Female; EUS-FNA: Endoscopic ultrasonography-guided fine needle aspiration.